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Abstract
Background: There are limited findings about dietary patterns and food preferences among
patients suffering from schizophrenia. The main objective of this study was therefore to compare
the nutritional pattern of schizophrenia patients with that of matched healthy subjects.
Methods: The dietary pattern of 30 hospitalized 16–67 years old schizophrenic patients (11
female) was compared with that of 30 healthy age and sex matched individuals as control group.
Subjects' anthropometric measurements including weight, height and body mass index (BMI), semi-
quantitative food frequency (FFQ), medical and food history questionnaires were also collected and
FFQs were then scored using Food Guide Pyramid to obtain the dietary scores. Percent body fat
(%BF) was measured using bioelectrical impedance analysis (BIA) method.
Results: Female patients had more %BF and lower dietary pattern scores than that of their
controls (32 ± 3.6 vs 27.7 ± 4.6 percent and 43.2 ± 11.9 vs 54.5 ± 10.7 points; respectively, p <
0.05 for both). They also consumed less milk and dairy products, fresh vegetables, fruits, chicken,
and nuts compared with the female controls (p < 0.03). However, these patients used to eat more
full-fat cream and carbonated drinks (p < 0.05). Male patients had lower BMI (22 ± 4.7 vs 25.6 ±
4.4; p < 0.05) than their counterpart controls but there was no significant difference between their
%BFs. Moreover, they used to have more full-fat cream, hydrogenated fats, less red meat and nuts
compared with the male controls (p < 0.05).
Conclusion: Schizophrenia patients have poor nutritional patterns. In particular, female patients
have more percent body fat and lower dietary pattern scores compared with their healthy controls.
All patients used to consume more fats and sweet drinks frequently. The findings of this study
suggest that schizophrenia patients need specific medical nutrition therapies through limiting
dietary fats and sugars intakes and weight control. Whether obesity is the consequence of disease,
dietary preference or medications used remains to be cleared.
Background
While it is well recognized that the pattern of food intake
is of substantial importance in the etiology of physical dis-
eases such as diabetes, cancer, and cardiovascular disease
and in the view of the clinical and epidemiological associ-
ation between these mental and physical illnesses, it is
surprising that there has been little research finding in the
relationship between nutrition and mental illness [1-3].
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On the other hand, some physical illnesses, particularly
diabetes and coronary heart disease, occur with increased
frequency in patients with schizophrenia and major
depression [2,4].
Peet compared the existing database on international var-
iations in the outcome of schizophrenia and showed that
more intake of refined sugar, meat, eggs, and with a lesser
degree dairy products and alcohol, was associated with a
greater prevalence of depression and poor outcome of
schizophrenia [1]. There was a negative (beneficial) rela-
tionship between pulses, fish and seafood intake and
severity of schizophrenia (expressed as hospital admis-
sion and social outcome) and prevalence of depression,
respectively [1]. Previously, Christensen and Christensen
showed that there is a very strong correlation between a
low percentage of total dietary fat and fat from land ani-
mals and birds (mainly saturated fats) and a good progno-
sis of schizophrenia. A high percentage of dietary
unsaturated fatty acids was less strongly associated [5].
Peet in his review has concluded that high saturated fats,
high glycemic load, and low omega-3 polyunsaturated
fatty acids (PUFA) may be detrimental to the symptoms of
schizophrenia [6].
However, at present, there are limited findings on nutri-
tional status and dietary practices of schizophrenia
patients. Therefore, this study has been carried out to
compare the food intake of schizophrenic patients with
that of healthy subjects and to find more practical nutri-
tional recommendations for this type of patients.
Methods
Subjects
Thirty schizophrenia patients (11 females) within range
of 16–76 years hospitalized in psychiatry ward were
recruited. They were diagnosed and admitted by the
attending psychiatrists. Patients had more than one-year
history of disease and hospitalized in Ahvaz University
Golestan Medical Center at least for one week. Controls (n
= 30; 14 female) were age-matched (within 5 years) indi-
viduals selected from the patients' siblings, friends and/or
people who have been living within similar areas com-
pared to the patients and had no specific history of psychi-
atric, psychologic, neurologic, and metabolic diseases.
Moreover, there was no statistically significant difference
in sex distribution between groups. All patients' families
declared their consents verbally and they were assured
that all information will be confidential and no blood
sampling will be done in this study. Moreover, there was
no need to reveal the patients' names. Medical Ethics
Committee of Jundi-Shapour University has approved the
study protocol.
Measurements
Data collection was carried out during spring 2004. Varia-
bles collected were anthropometric indices including
weight and height, socio-economic status, medical and
food histories. Semi-quantitative food frequency ques-
tionnaires were also completed. In these questionnaires,
the patients' usual dietary patterns were recorded. Sub-
ject's weight and height were measured using Seca digital
scale; Germany, and a non-stretchable wall meter, respec-
tively. Individual's body mass index (BMI) was calculated
as weight (Kg) divided by squared height (m2) and sub-
ject's percent body fat (%BF) was measured using the bio-
electrical impedance analysis (BIA) method by OMRON
BF-302; Japan with standard errors of estimate (accuracy)
of 4.1%. Food frequency questionnaires were then scored
on the basis of the Food Guide Pyramid and Mediterra-
nean Pyramid and interpreted as dietary scores.
Statistics
Data were analyzed by independent-t and Chi-square tests
using SPSS soft-ware version # 11.5. P value less than 0.05
was regarded as significant.
Results
There was no significant difference between the mean age
of the patients and the controls. Table 1 represents the
anthropometric criteria and dietary scores of both female
groups. Dietary scores of female patients were signifi-
cantly lower while their %BFs were higher than that of
their controls (p < 0.05). Male patients were shorter while
their BMIs were higher than their controls (p < 0.05).
Table 2 shows the consumption of the main food groups
in study groups based on their sexes. More male patients
used to eat hydrogenated fats (about 2.3 times more; p =
0.03), and full-fat cream (7 times more; p = 0.005) but
fewer ate red meats (about one eighth; p = 0.02), vegeta-
ble oils (p = 0.001), and nuts (p = 0.01) servings per day
compared with their controls. More female patients used
to drink carbonated drinks (p = 0.006) but fewer con-
sumed milk, vegetables, nuts, and sausages servings daily
(P < 0.05 for all).
In comparison with the female patients, more men used
to eat vegetables, eggs, cream and chocolate (p < 0.05 for
all) but fewer ate tuna fish servings (p = 0.02; table 3). All
patients used to consume full-fat cream and chocolate in
their daily food patterns.
Discussion
Previous studies have shown that dietary fats are associ-
ated with adverse outcome in schizophrenia [5-7]. How-
ever, diet is much more complex than this and dietary
intake of different food stuff is highly intercorrelated. For
example, people who eat a lot of saturated fat will gener-BMC Psychiatry 2007, 7:15 http://www.biomedcentral.com/1471-244X/7/15
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ally also eat a lot of sugar [8]. It was also shown that meat,
dairy products, and saturated fat intake were associated
with poor outcome of schizophrenia [1,4,5].
The results of the present study showed that schizophre-
nia patients, especially women, had low overall dietary
scores than their healthy matched controls, based on the
Food Guide Pyramid [9]. Moreover, females were clini-
cally overfat (%BF 32 ± 3.6) in comparison with their con-
trols.
At the same time, male patients had higher BMI values
than their controls (the former defined as overweight).
Strassing et al have indicated that excess body weight in
schizophrenic patients is associated with serious health
risks. They also reported that female patients were more
likely to approach weight loss than males [10]. Weiser et
al followed the hospitalization of the schizophrenia
patients among male adolescents who had been assessed
by a national psychiatric registry for 2–6 years and they
showed that these patients before the onset of illness,
were not heavier than their peers and the increased weight
of patients was related to illness effects e.g. antipsychotic
medication [11].
In this study, majority of the male patients (83%) used to
eat hydrogenated fats as well as full-fat cream daily but
vegetable oils intake was much lower in comparison with
their controls. It should be noted that most Iranians are
traditionally consuming hydrogenated fats (ghee) in their
daily diets and this is the main reason for high propor-
tions seen even in the healthy subjects here.
Based on the results obtained female patients' overall
food pattern scores were significantly lower than their
controls and also the male patients.
Table 2: Consumption of food groups in schizophrenia patients and their controls separated by sex.1
Male(n = 35) Female(n = 25)
Food groups Servings* Patients Controls p value Patients Controls p value
N o% N o% N o% N o%
Milk 1–2/d 6 32 5 31 0.9 2 18 5 36 0.03
Vegetables 1–2/d 13 68 7 44 0.6 4 36 6 43 0.04
Fruits 3/d 10 53 12 75 0.3 7 64 14 100 0.1
Meats 1–2/d 1 5 6 38 0.02 2 18 7 50 0.08
Tuna fish 1–2/wk 5 26 7 44 0.2 3 27 4 29 0.9
Chicken 1–2/d 15 79 16 100 0.2 5 45 14 100 0.02
Eggs 1–2/d 15 79 12 75 0.3 5 45 10 71 0.3
Hydrogenated
Oils 3–5/d 16 83 13 37 0.03 7 64 11 79 0.3
Vegetables
Oils 3–5/d 10 53 15 94 0.001 5 45 11 79 0.08
Cream 1–2/d 8 42 1 6 0.005 2 18 0 0 0.2
Nuts 1–2/d 2 10 4 25 0.01 2 18 10 71 0.03
Carbonated
Drinks 1–2/d 4 21 3 19 0.08 4 36 0 0 0.006
Sausages 1–2/d 10 53 4 25 0.08 2 18 5 36 0.03
Chocolate 1–2/d 8 42 8 50 0.08 2 18 5 36 0.2
1- Data based on semi-quantitative food frequency questionnaires.
* Servings are presented based on Food Guide Pyramid and Mediterranean Pyramid
Table 1: Basic characteristics of the subjects†
Criteria Male Female
Patients Controls Patients Controls
Age (y) 32. 3 ± 9 35.6 ± 14 32.5 ± 9.2 36.6 ± 9.5
Weight (Kg) 68.4 ± 14 73.7 ± 10.6 66.9 ± 10.7 66.8 ± 12.3
Height (Cm) 176.5 ± 7.6 170 ± 8 * 160 ± 6.3 162 ± 4.9
BMI (Kg/m2) 22 ± 4.7 25.6 ± 4.4* 26 ± 3.6 25.4 ± 3.8
Percent body fat 14.3 ± 9 14.6 ± 3 32 ± 3.6 27.7 ± 4.6*
Dietary scores 54.8 ± 6.7 57 ± 7.7 43.2 ± 11. 9 54.5 ± 10.7*
† Data are shown as: Mean ± SD.
* p < 0.05BMC Psychiatry 2007, 7:15 http://www.biomedcentral.com/1471-244X/7/15
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Moreover, patients drank more carbonated drinks but
fewer ate vegetable oils and nuts, both are recognized as
good sources of antioxidants such as vitamin E and caro-
tenoids and as well as essential fatty acids. By obtaining
24-h diet recall questionnaires of 146 patients with schiz-
ophrenia, Strassing et al. found that saturated and poly
unsaturated fatty acid intake was significantly higher in
patients than in controls, but there were no differences
with regard to dietary intake of omega-3 fatty acids and
antioxidants [12]. WHO have reported that countries with
a higher saturated fat intake from land animal and bird
sources had worse outcome of schizophrenia than coun-
tries with relatively higher PUFA intake from fish, seafood
and vegetables, thereby confirming the observation of a
better outcome of schizophrenia in developing countries
than in industrialized countries [13]. More recently,
abnormalities in cell membrane phospholipid metabo-
lism of schizophrenia patients, including low PUFA brain
content [14,15] or RBC membranes [16] have been
described.
However, it is known that patients with schizophrenia
make poor dietary choices [17] and their tendency to have
increased caloric intake including a higher total dietary fat
consumption than healthy individuals has been indicated
previously [18]. Hence, becoming overfat and/or obese
could enhance their risk of other complications. These
findings are in agreement with those presented here.
There are reports indicating that schizophrenia patients
may be exposed to increased oxidative stress when com-
pared to the population [19] which could be due to
increased peroxidative stress during acute phase of disease
[20], increased smoking [21] or prolonged treatment with
antipsychotic medication [22].
The results presented here also showed that fewer female
patients used to consume fresh vegetables than their con-
trols and male patients. There was no difference in fruit
consumption between two study groups. Both fresh fruits
and vegetables are good sources of dietary antioxidants.
However, antioxidants intake and their serum levels in
this type of patients need further investigations.
It is worthy to note that some findings presented here, in
fact, are statistical associations rather than cause and effect
relationships hence, expose time and outcomes should be
evaluated in more details in another setting.
Finally, this research was a pilot study and all of the
patients in the ward were selected in a simple sampling
procedure, therefore, case-control studies with more
number of subjects, and preferably, longitudinal cohort
studies, are needed to compare both the intakes and
serum levels of certain nutrients. Furthermore, no clear
conclusion can be made regarding cause and effect rela-
tionships between dietary practices and etiology and/or
severity of schizophrenia. Because of limited information
available about dietary practices and nutritional require-
ments in schizophrenia, the present findings can be
regarded as a small step toward practical implications for
Table 3: Consumption of food groups in schizophrenia patients and their controls separated by the study group.1
Patients(n = 30) Controls(n = 30)
Food groups Servings* Male Female p value Male Female p value
No % No % No % No %
Milk 1–2/d 6 32 2 18 0.07 5 31 5 36 0.08
Vegetables 1–2/d 13 69 4 36 0.01 7 44 6 43 0.7
Fruits 1–2/d 10 53 7 64 0.2 12 75 14 100 0.07
Meats 1–2/d 1 5 2 18 0.6 6 38 7 50 0.5
Tuna fish 1–2/wk 3 16 7 64 0.02 5 31 8 57 0.3
Chicken 1–2/wk 15 79 5 45 0.1 16 100 14 100 -
Eggs 1–2/d 15 79 5 45 0.01 12 75 10 71 0.2
Hydrogenated
Oils 3–5/d 16 84 13 81 0.02 7 64 11 79 0.3
Vegetables
Oils 3–5/d 10 53 5 45 0.4 15 94 11 79 0.2
Cream 1–2/d 8 42 2 18 0.6 1 6 0 0 0.05
Nuts 1–2/d 2 10 2 18 0.6 4 25 10 71 0.02
Carbonated
Drinks 1–2/d 4 21 4 36 0.3 3 19 0 0 0.01
Sausages 1–2/d 10 53 2 18 0.1 4 25 5 36 0.3
Chocolate 1–2/d 8 42 2 18 0.05 8 50 5 36 0.03
1- Data based on semi-quantitative food frequency questionnaires.
* Servings are prensented based on Food Guide Pyramid and Mediterranean Pyramid.Publish with BioMed Central    and   every 
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clinicians and dieticians. It is suggested that all schizo-
phrenic patients need more dietary assessment and spe-
cific nutritional cares.
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